Seongnam, South Korea

Inho Yang

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Bisichem Co., Ltd., Bisichem Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Inho Yang. Retrieved from https://idiyas.com/inventor/inho-yang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inho Yang: Innovator in Heterocyclic Compounds

Introduction

Inho Yang is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals through his innovative work on heterocyclic compounds. His research focuses on developing novel compounds that have potential therapeutic applications.

Latest Patents

Inho Yang holds a patent for "Fused ring heteroaryl compounds and use thereof." This invention provides novel substituted heterocyclic compounds represented by Formula I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer, or prodrug thereof. The compounds can be used as inhibitors of ALK5 and are useful in the treatment of chronic fibrosis, vascular disorders, obesity, diabetes, autoimmune diseases, and cancer. He has 1 patent to his name.

Career Highlights

Inho Yang is currently associated with Bisichem Co., Ltd., where he continues to advance his research in the pharmaceutical industry. His work has the potential to impact various medical conditions significantly.

Collaborations

Inho Yang collaborates with talented individuals such as Jinwoo Lee and Byungnam Kang, contributing to a dynamic research environment.

Conclusion

Inho Yang's innovative work in the field of heterocyclic compounds showcases his commitment to advancing medical science. His contributions have the potential to lead to significant breakthroughs in the treatment of various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…